Artiva Biotherapeutics to participate in September investor conferences
Artiva Biotherapeutics announced management will participate in upcoming investor conferences in September.
SAN DIEGO, Sept.
02, 2026 (GLOBE NEWSWIRE) -- Artiva Biotherapeutics, Inc.
NASDAQ:ARTV (Artiva), a clinical-stage biotechnology company whose mission is to develop effective, safe and accessible cell therapies for patients with debilitating autoimmune diseases, today announced that management will…